Search
Business Practice
View More
Business
Development
Legal
Policy
Practice
Regulatory
Business
Development
Legal
Policy
Practice
Regulatory
News
All News
Product Approvals and Launches
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
Subscribe
BIOSIMILAR APPROVALS
Search
Advertisement
Business Practice
See All >
Business
Development
Legal
Policy
Practice
Regulatory
Global Perspective on the Effect of Biosimilars
EP. 1: Comparison of Biologics to Biosimilars Versus Generics
October 10th 2018
EP. 2: The BPCIA and the Naming of Biosimilars
October 10th 2018
EP. 3: The Approval Process for Biosimilars
October 10th 2018
EP. 4: Considerations for Approving Generics Versus Biosimilars
October 10th 2018
EP. 5: Interchangeability and Postmarketing Pharmacovigilance of Biosimilars
October 10th 2018
EP. 6: Experience Prescribing Biosimilars Versus Biologics
October 10th 2018
EP. 7: The Impact of Access to Biosimilars
October 10th 2018
EP. 8: US and EU Biosimilar Pricing and Stakeholder Education
October 10th 2018
EP. 9: Formulary Approval and Challenges for Payers
October 10th 2018
EP. 10: Prescribing Biosimilars and Educating Patients and Physicians
October 10th 2018
Next >>
Advertisement
Advertisement
